Medicare Enrolled

Dr. Cole Pomykacz, PA-C

Medical Physician Assistant · Stuart, FL
Low-engagement
433 SE OCEAN BLVD, Stuart, FL 34994
7722235955
In practice since 2021 (5 years)
NPI: 1144814815 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Pomykacz from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Pomykacz? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Pomykacz

Dr. Cole Pomykacz is a medical physician assistant in Stuart, FL, with 5 years in practice.

Between the years covered by Open Payments, Dr. Pomykacz received a total of $8,730 from 65 pharmaceutical and/or device companies across 428 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical physician assistant. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Pomykacz is Moderate — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 5 years in practice$ $8,730 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$8,730
Total received (2021-2024)
Avg $2,182/year across 4 years
Top 4% in FL for medical physician assistant
65
Companies
428
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,363 (95.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$366 (4.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,093
2023
$2,492
2022
$1,809
2021
$1,336

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Celgene Corporation
$717
Janssen Biotech, Inc.
$712
AstraZeneca Pharmaceuticals LP
$684
Merck Sharp & Dohme LLC
$491
Daiichi Sankyo Inc.
$487
PFIZER INC.
$360
Novartis Pharmaceuticals Corporation
$347
Amgen Inc.
$333
Incyte Corporation
$305
E.R. Squibb & Sons, L.L.C.
$223
GlaxoSmithKline, LLC.
$209
Seagen Inc.
$199
Lilly USA, LLC
$183
JAZZ PHARMACEUTICALS INC.
$176
Takeda Pharmaceuticals U.S.A., Inc.
$171
Bayer Healthcare Pharmaceuticals Inc.
$169
GENZYME CORPORATION
$165
Kyowa Kirin, Inc.
$159
Pharmacyclics LLC, An AbbVie Company
$153
Ipsen Biopharmaceuticals, Inc
$143
Mirati Therapeutics, Inc.
$139
Exelixis Inc.
$127
Merck Sharp & Dohme Corporation
$117
Pharmacosmos Therapeutics Inc.
$111
PUMA BIOTECHNOLOGY, INC.
$109
Bayer HealthCare Pharmaceuticals Inc.
$103
Eisai Inc.
$91
SERVIER PHARMACEUTICALS LLC
$88
Stemline Therapeutics Inc.
$87
Astellas Pharma US Inc
$79
SEAGEN INC.
$75
Regeneron Healthcare Solutions, Inc.
$74
Puma Biotechnology, Inc.
$69
Foundation Medicine, Inc.
$69
ABBVIE INC.
$66
ARRAY BIOPHARMA INC
$66
TerSera Therapeutics LLC
$64
SOBI, INC
$58
Aveo Pharmaceuticals, Inc.
$52
G1 Therapeutics, Inc.
$51
BeiGene USA, Inc.
$47
Genentech USA, Inc.
$47
ACCORD HEALTHCARE, INC.
$43
Teva Pharmaceuticals USA, Inc.
$41
Coherus Biosciences Inc.
$38
Alexion Pharmaceuticals, Inc.
$37
PharmaEssentia USA Corporation
$32
Dova Pharmaceuticals
$25
Biocon Biologics Inc
$25
Novocure Inc.
$25
Napo Pharmaceuticals Inc
$25
EUSA Pharma (US) LLC
$24
Mylan Institutional Inc.
$23
Gilead Sciences, Inc.
$21
Sobi, Inc
$20
Apellis Pharmaceuticals, Inc.
$20
Agios Pharmaceuticals, Inc.
$20
EMD Serono, Inc.
$19
Myriad Genetic Laboratories, Inc.
$19
RECORDATI_RARE_DISEASES_INC.
$18
ImmunoGen, Inc.
$17
MorphoSys, US Inc.
$17
Heron Therapeutics, Inc.
$16
Global Blood Therapeutics, Inc.
$16
Karyopharm Therapeutics Inc.
$14
Top 3 companies account for 24.2% of total payments
Associated products mentioned in payments ›
ADCETRIS · ALUNBRIG · Alecensa · Aliqopa · BENDEKA · BESREMI · BOSULIF · BRAFTOVI · BRUKINSA · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · CAMCEVI · CINVANTI · COSELA · Cimerli · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIQUIS · ELITEK · ENHERTU · ENJAYMO · EPKINLY · ERBITUX · Elahere · Empaveli · Enhertu · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fulphila · GELCLAIR CONCENTRATED ORAL GEL · Hulio · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · JAKAFI · JEMPERLI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LORBRENA · LUMAKRAS · LUPRON DEPOT · LUTATHERA · LYNPARZA · Lenvima · MONJUVI · MONOFERRIC · NERLYNX · NINLARO · Nubeqa · ONUREG · OPDIVO · OPDUALAG · OXBRYTA · Onivyde · Optune Lua (NovoTTF-200T) · Orserdu · PADCEV · PLUVICTO · PRECISETUMOR · Padcev · Pomalyst · Poteligeo · REBLOZYL · RYBREVANT · Revlimid · SARCLISA · SOMATULINE DEPOT · SYLVANT · Somatuline Depot · Stivarga · Sylvant · TAGRISSO · TALVEY · TECVAYLI · TIBSOVO · TIVDAK · TUKYSA · Tazverik · Tibsovo · ULTOMIRIS · Udenyca · VERZENIO · VONJO · Venclexta · XALKORI · XPOVIO · Xtandi · ZEJULA · ZEPZELCA · Zoladex
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 4% for medical physician assistant in FL.

Looking for a medical physician assistant in Stuart?
Compare medical physician assistants in the Stuart area by procedure volume, costs, and industry payment transparency.
Browse medical physician assistants nearby

Geographic Context

Medical Physician Assistants within 10 mi
71
Per 100K population
44.2
County median income
$80,701
Nearest hospital
CLEVELAND CLINIC MARTIN NORTH HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data— No dataN/A
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Moderate. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Pomykacz is a medical physician assistant, and high industry engagement (low-engagement, top 4%).

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Pomykacz receive payments from pharmaceutical companies?
Yes. Dr. Pomykacz received a total of $8,730 from 65 companies across 428 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Pomykacz) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →